Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming
Advanced Science · 2024-09 · 11 (34)
DOI: 10.1002/advs.202404886 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 07.07.2024. Verfasst von Yeneng Dai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Centre, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, SAR, 999078, China. Hauptthemen laut MEDLINE: Immunotherapy, Tumor Microenvironment. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Guangdong Province, Science and Technology Development Fund of Macau.
Abstract (Originalsprache)
Immune checkpoint blockade (ICB) immunotherapy remains hampered by insufficient immunogenicity and a high‐lactate immunosuppressive tumor microenvironment (TME). Herein, a nanobody‐engineered NIR‐II nanoadjuvant with targeting metabolic reprogramming capability is constructed for potentiating NIR‐II photothermal‐ferroptosis immunotherapy. Specifically, the nanoadjuvant (2DG@FS‐Nb) is prepared by metallic iron ion‐mediated coordination self‐assembly of D‐A‐D type NIR‐II molecules and loading of glycolysis inhibitor, 2‐deoxy‐D‐glucose (2DG), followed by modification with aPD‐L1 nanobody (Nb), which can effectively target the immunosuppressive TME and trigger in situ immune checkpoint blockade. The nanoadjuvants responsively release therapeutic components in the acidic TME, enabling the precise tumor location by NIR‐II fluorescence/photoacoustic imaging while initiating NIR‐II photothermal‐ferroptosis therapy. The remarkable NIR‐II photothermal efficiency and elevated glutathione (GSH) depletion further sensitize ferroptosis to induce severe lipid peroxidation, provoking robust immunogenic cell death (ICD) to trigger anti‐tumor immune response. Importantly, the released 2DG markedly inhibits lactate generation through glycolysis obstruction. Decreased lactate efflux remodels the immunosuppressive TME by suppressing M2 macrophage proliferation and downregulating regulatory T cell levels. This work provides a new paradigm for the integration of NIR‐II phototheranostics and lactate metabolism regulation into a single nanoplatform for amplified anti‐tumor immunotherapy combined with ICB therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Centre, Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, SAR, 999078, China.
- State Key Laboratory of Organic Electronics and Information Displays & Jiangsu Key Laboratory for Biosensors, Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, Nanjing, 210023, Chi…
- School of Life Sciences, Central South University, Changsha, 410013, China.
- MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau, SAR, 999078, China.
ORCID-Profile: Qi Zhao
Förderung
- National Key Research and Development Program of China
- Natural Science Foundation of Guangdong Province
- Science and Technology Development Fund of Macau
- University of Macau
- National Natural Science Foundation of China
- Huali Talents Program of Nanjing University of Posts and Telecommunications
- Natural Science Foundation of Jiangsu Province
- Universidade de Macau
Zitieren
APA
Dai, Y., Guo, Z., Leng, D., Jiao, G., Chen, K., Fu, M., Liu, Y., Shen, Q., Wang, Q., Zhu, L., & Zhao, Q. (2024). Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming. Advanced Science, 11(34). https://doi.org/10.1002/advs.202404886
Vancouver
Dai Y, Guo Z, Leng D, Jiao G, Chen K, Fu M, et al. Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming. Advanced Science. 2024;11(34). doi:10.1002/advs.202404886
BibTeX
@article{Dai2024,
author = {Dai, Yeneng and Guo, Ziang and Leng, Dongliang and Jiao, Guanda and Chen, Kai and Fu, Mingxuan and Liu, Yang and Shen, Qingming and Wang, Qi and Zhu, Lipeng and Zhao, Qi},
title = {Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {34},
doi = {10.1002/advs.202404886}
}
EUVIMED